EmCare Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EmCare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12335
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EmCare Inc (EmCare) is a healthcare service provider that offers emergency department outsourcing services for the hospitals. The center provides emergency medicine, hospital medicine, acute care surgery, anesthesiology and radiology services. It provides recruitment, staffing, management, metric improvement programs and billing collection services for emergency medicine. EmCare offers better communication; more practices; better quality of care and clinical outcomes; improved patient, medical staff and referring physician satisfaction; and improved metrics. The center serves client contracts and hospitals across the US. It has operations in Dallas, Horsham, Clearwater, Santa Barbara and Pensacola, the US. EmCare is headquartered in Dallas, Texas, the US.

EmCare Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EmCare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EmCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
EmCare Inc, Pharmaceuticals & Healthcare, Deal Details 9
Acquisition 9
EmCare Acquires Emergency Medical Associates and Scottsdale Emergency Associates for USD380 Million 9
EmCare Completes Acquisition of Phoenix Physicians for USD170 Million 10
EmCare Acquires Saint Vincent Anesthesia Medical And Golden State Anesthesia Consultants 11
EmCare Inc – Key Competitors 12
EmCare Inc – Key Employees 13
EmCare Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
EmCare Inc, Pharmaceuticals & Healthcare, Key Facts 2
EmCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EmCare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EmCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
EmCare Acquires Emergency Medical Associates and Scottsdale Emergency Associates for USD380 Million 9
EmCare Completes Acquisition of Phoenix Physicians for USD170 Million 10
EmCare Acquires Saint Vincent Anesthesia Medical And Golden State Anesthesia Consultants 11
EmCare Inc, Key Competitors 12
EmCare Inc, Key Employees 13
EmCare Inc, Other Locations 14
EmCare Inc, Subsidiaries 14

List of Figures
EmCare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EmCare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EmCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[EmCare Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ASX Ltd (ASX):企業の財務・戦略的SWOT分析
    ASX Ltd (ASX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TonenGeneral Sekiyu K.K. (5012)-石油・ガス分野:企業M&A・提携分析
    Summary TonenGeneral Sekiyu K.K. (TonenGeneral) is an energy company that imports, refines and processes crude oil. It also manufactures, distributes and markets petroleum and petrochemical products. The company’s product portfolio includes lubricants, naphtha, sulphur, kerosene, hydrocarbon resin, …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Deyaar Development:企業の戦略・SWOT・財務情報
    Deyaar Development - Strategy, SWOT and Corporate Finance Report Summary Deyaar Development - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Innovation Pharmaceuticals Inc (IPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that offers discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company offers kevetrin for t …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bravura Solutions Limited (BVA):企業の財務・戦略的SWOT分析
    Bravura Solutions Limited (BVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GenomeDx Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Imperial Brands Plc:企業の戦略・SWOT・財務情報
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Shine Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shine Medical Technologies Inc (Shine Medical) is a manufacturer and supplier of medical tracers and cancer treatment elements. The company’s products include molybdenum-99 is the parent isotope of technetium 99m for diagnosing and staging multitude of diseases, including cancer and heart di …
  • Bangkok Insurance Pcl:企業の戦略・SWOT・財務分析
    Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report Summary Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆